Tag: #pharma

Pfizer Keeps 2026 Outlook as Q1 Revenue Rises 5%; COVID Sales Slide

Pfizer posted 5% revenue growth in Q1 and kept its 2026 outlook, as gains from newer drugs offset steep declines in Comirnaty and Paxlovid sales.

$PFE, #pfizer, #earnings, #pharma

Biogen Signals $34 Million Deal-Related Charge as It Reshapes Earnings Strategy

Biogen warns of a $34M charge tied to licensing and research deals, underscoring the rising cost and volatility of its deal-driven strategy.

#biogen, #biotechnology, #earnings, #deal, #pharma

Lilly’s daily GLP-1 pill beats Novo’s oral semaglutide in diabetes trial, but side effects drive more dropouts

A Phase 3 head-to-head study finds Lilly’s orforglipron lowered A1c and weight more than Rybelsus, with higher quit rates.

#diabetes, #glp1, #weightloss, #pharma, #clinicaltrials